These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24997673)

  • 1. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.
    Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
    Neurobiol Aging; 2014 Dec; 35(12):2691-2700. PubMed ID: 24997673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.
    Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP
    J Alzheimers Dis; 2014; 41(3):819-33. PubMed ID: 24685637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease.
    Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; Martin JJ; De Deyn PP
    Alzheimers Res Ther; 2015; 7(1):7. PubMed ID: 25717350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
    Vermeiren Y; Janssens J; Aerts T; Martin JJ; Sieben A; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2016 Jun; 53(3):1079-96. PubMed ID: 27314528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients.
    Storga D; Vrecko K; Birkmayer JG; Reibnegger G
    Neurosci Lett; 1996 Jan; 203(1):29-32. PubMed ID: 8742039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of monoaminergic neurotransmitters in fetal and postnatal rat brain: analysis by HPLC with electrochemical detection.
    Herregodts P; Velkeniers B; Ebinger G; Michotte Y; Vanhaelst L; Hooghe-Peters E
    J Neurochem; 1990 Sep; 55(3):774-9. PubMed ID: 1696620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
    Nazarali AJ; Reynolds GP
    Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
    Carlsson A; Adolfsson R; Aquilonius SM; Gottfries CG; Oreland L; Svennerholm L; Winblad B
    Adv Biochem Psychopharmacol; 1980; 23():295-304. PubMed ID: 6156586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
    Andreou D; Saetre P; Kähler AK; Werge T; Andreassen OA; Agartz I; Sedvall GC; Hall H; Terenius L; Jönsson EG
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):700-4. PubMed ID: 21295953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorpromazine-induced alterations in hypothalamic amine metabolism and stress responses in severe cold.
    Kortelainen ML; Lapinlampi T; Hirvonen J
    Z Rechtsmed; 1989; 102(6):377-90. PubMed ID: 2472037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).
    Gottfries CG; Adolfsson R; Aquilonius SM; Carlsson A; Eckernäs SA; Nordberg A; Oreland L; Svennerholm L; Wiberg A; Winblad B
    Neurobiol Aging; 1983; 4(4):261-71. PubMed ID: 6200784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical variables in delusional depression.
    Lykouras E; Markianos M; Malliaras D; Stefanis C
    Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.
    Trillo L; Das D; Hsieh W; Medina B; Moghadam S; Lin B; Dang V; Sanchez MM; De Miguel Z; Ashford JW; Salehi A
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1363-79. PubMed ID: 23707776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
    Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J
    Arch Gen Psychiatry; 1983 Sep; 40(9):999-1010. PubMed ID: 6193764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 18. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine metabolism in senile dementia of Alzheimer type.
    Cross AJ; Crow TJ; Johnson JA; Joseph MH; Perry EK; Perry RH; Blessed G; Tomlinson BE
    J Neurol Sci; 1983; 60(3):383-92. PubMed ID: 6195313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.